Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Urothelial Cancer

NCT02560038 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT02560038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02560038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Urothelial Cancer
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2015
Completion date
September 14, 2017
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urinary bladder neoplasms